Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

about

Knowledge, attitude, and practice on and willingness to pay for human papillomavirus vaccine: a cross-sectional study in Hanoi, Vietnam.Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk-benefit balance.

P2860

Q55177475-9CDD8D7D-B9AD-4395-AF7F-0EF791A12B2E Q55277306-A132DFCD-4DCB-4F0F-B9DC-4867565556B0

P2860

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

Item

http://www.wikidata.org/entity/Q55261252

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

@en

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

@nl

type

Item

label

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

@en

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

@nl

prefLabel

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

@en

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

@nl

P1476

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

@en

P2093

André Dahlab

http://www.w3.org/2001/XMLSchema#string

Marjorie Adam

http://www.w3.org/2001/XMLSchema#string

Mathieu Uhart

http://www.w3.org/2001/XMLSchema#string

Xavier Bresse

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.

Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Polio eradication, cessation of vaccination and re-emergence of disease.

Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine.

Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France.

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

P304

73-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PVR.2017.02.004

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28720460

http://www.w3.org/2001/XMLSchema#string

P932

5883194

http://www.w3.org/2001/XMLSchema#string

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

about

P2860

P2860

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932